One can easily count the chickens of non-pharmacological approaches highlighted in multiple organizational guidelines and state strategies related to pain and opioids. But one definitely cannot count on them hatching inside each new, significant policy initiative. Regular medicine tends to regress toward a non-inclusive mean in pain treatment. And “mean”
To gain access to this article and the rest of our extensive database of full-text articles, please register below or log in here.
Inclusion Check-in: Are Integrative Practices in New Federal Opioid Legislation, National Academy, and FDA Activity?
Read more
To gain access to this article and the rest of our extensive database of full-text articles, please register below or log in here.
Related Articles
The Bone-Loss Problem in the GLP-1 Era
Read MoreGalectin-3 and Apheresis: The Future of Medicine
Read MoreNicotinamide for Non-Melanoma Skin Cancer Prevention: What the Evidence Shows
Read More